Existing natural promoters often lack the necessary strength, specificity, or regulatory precision required for effective transgene expression. Developing novel synthetic alternatives overcomes the limitations of low yield and poor temporal control in genetic engineering.

Standard endogenous promoters lack the transcriptional strength or regulatory control to drive high-yield industrial biosynthesis. Overcoming this bottleneck enables the commercial production of glutathione through enhanced enzymatic expression.